Yes, NovoLog is a rapid-acting insulin. It is one of the fastest insulin options available, beginning to work within 10 to 15 minutes of injection. The FDA classifies NovoLog (insulin aspart) as a rapid-acting human insulin analog, and it is designed to be taken just before meals to manage blood sugar spikes from food.
How Fast NovoLog Works
NovoLog starts lowering blood glucose within about 15 minutes of a subcutaneous injection. It reaches peak activity between 1 and 3 hours, then tapers off over a total duration of 3 to 5 hours. Because of this speed, you should inject NovoLog 5 to 10 minutes before eating and then start your meal promptly. Skipping or delaying a meal after injecting can cause blood sugar to drop too low.
For comparison, regular human insulin (sold as Novolin R or Humulin R) takes 30 to 60 minutes to kick in. That means NovoLog starts working roughly two to four times faster, which makes it much better at catching the blood sugar surge that happens right after you eat.
Why It Acts Faster Than Regular Insulin
Regular human insulin molecules naturally clump together into groups of six (called hexamers) when injected under the skin. Those clumps have to break apart before individual insulin molecules can enter the bloodstream, and that takes time. NovoLog has one amino acid swapped out compared to natural human insulin, replacing proline with aspartic acid at a single position in the molecule. That tiny change reduces the tendency to clump, so more individual molecules absorb into the bloodstream quickly after injection.
How NovoLog Is Taken
NovoLog is injected subcutaneously, meaning just under the skin. Recommended injection sites include the abdomen, thigh, buttocks, or upper arm. It comes in three forms: a 10 mL vial for use with syringes, a 3 mL cartridge for reusable pen devices, and a prefilled disposable pen called the FlexPen. All contain 100 units per milliliter.
NovoLog is also compatible with external insulin pumps, which deliver a continuous low dose throughout the day plus extra doses at mealtimes. Pump users still get the same rapid onset. In hospital settings, NovoLog can be given intravenously under medical supervision for tighter blood sugar control, though this isn’t something patients do at home.
Storage After Opening
Unopened NovoLog should be stored in the refrigerator. Once you open a vial, pen, or cartridge, it can be kept at room temperature (between 59°F and 86°F) for up to 28 days. After 28 days at room temperature, the insulin should be discarded even if there is product remaining. Heat and direct sunlight degrade insulin, so avoid leaving it in a car or near a window.
NovoLog During Pregnancy
Based on data from 437 pregnancies, insulin aspart does not appear to increase the chance of birth defects, miscarriage, preterm delivery, or low birth weight above the normal background risk. Managing blood sugar during pregnancy is critical for both the parent and baby, and NovoLog’s rapid action helps control post-meal glucose spikes, which tend to be more pronounced during pregnancy.
How It Fits With Other Insulins
Rapid-acting insulins like NovoLog are typically paired with a long-acting (basal) insulin that provides a steady baseline of blood sugar control throughout the day. NovoLog handles the sharp glucose rises after meals, while the basal insulin covers the hours in between. This combination mimics the way a healthy pancreas releases insulin: a low, constant drip plus bursts at mealtimes.
Other rapid-acting insulins in the same category include insulin lispro and insulin glulisine. All three share similar onset times and durations, though individual responses can vary slightly. NovoLog’s 10 to 15 minute onset, 1 to 3 hour peak, and 3 to 5 hour total duration make it a close match to the others in its class. The choice between them often comes down to insurance coverage, device preference, or how a specific person responds.